Neogen Stock (NASDAQ:NEOG)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$12.02

52W Range

$11.46 - $20.89

50D Avg

$14.08

200D Avg

$14.94

Market Cap

$2.61B

Avg Vol (3M)

$1.68M

Beta

1.22

Div Yield

-

NEOG Company Profile


Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Show More

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

2,917

IPO Date

Aug 23, 1989

Website

NEOG Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceMay 24May 23May 22
Product$821.82M$715.08M$424.66M
Service$102.40M$107.37M$102.50M

Fiscal year ends in May 24 | Currency in USD

NEOG Financial Summary


May 24May 23May 22
Revenue$924.22M$822.45M$527.16M
Operating Income$58.66M$37.52M$34.92M
Net Income$-9.42M$-22.87M$48.31M
EBITDA$58.66M$37.52M$58.62M
Basic EPS$-0.04$-0.12$0.45
Diluted EPS$-0.04$-0.12$0.45

Fiscal year ends in May 24 | Currency in USD

Latest Earnings Call Transcripts


Q1 25Oct 10, 24 | 1:42 PM
Q4 24Jul 30, 24 | 12:33 PM
Q3 24Apr 09, 24 | 10:11 AM

Peer Comparison


TickerCompany
ICLRICON Public Limited Company
SERASera Prognostics, Inc.
RDNTRadNet, Inc.
QGENQiagen N.V.
ACRSAclaris Therapeutics, Inc.
IQVIQVIA Holdings Inc.
XGNExagen Inc.
BNRBurning Rock Biotech Limited
FONRFONAR Corporation
MEDPMedpace Holdings, Inc.
MYGNMyriad Genetics, Inc.
SHCSotera Health Company